These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12044579)

  • 1. The extracellular matrix on atherogenesis and diabetes-associated vascular disease.
    Camejo G; Olsson U; Hurt-Camejo E; Baharamian N; Bondjers G
    Atheroscler Suppl; 2002 May; 3(1):3-9. PubMed ID: 12044579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis.
    Camejo G; Hurt-Camejo E; Wiklund O; Bondjers G
    Atherosclerosis; 1998 Aug; 139(2):205-22. PubMed ID: 9712326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty acids cause alterations of human arterial smooth muscle cell proteoglycans that increase the affinity for low-density lipoprotein.
    Rodríguez-Lee M; Ostergren-Lundén G; Wallin B; Moses J; Bondjers G; Camejo G
    Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):130-5. PubMed ID: 16239593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PPAR agonists in the treatment of insulin resistance and associated arterial disease.
    Camejo G
    Int J Clin Pract Suppl; 2003 Mar; (134):36-44. PubMed ID: 12793596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase A(2) in vascular disease.
    Hurt-Camejo E; Camejo G; Peilot H; Oörni K; Kovanen P
    Circ Res; 2001 Aug; 89(4):298-304. PubMed ID: 11509445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatty acid-induced atherogenic changes in extracellular matrix proteoglycans.
    Rodriguéz-Lee M; Bondjers G; Camejo G
    Curr Opin Lipidol; 2007 Oct; 18(5):546-53. PubMed ID: 17885426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Why are plasmatic apoB lipoproteins atherogenic? The hypothesis of response to retention].
    Hurt-Camejo E; Camejo G
    Invest Clin; 2001 May; 42 Suppl 1():43-73. PubMed ID: 11416984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in matrix proteoglycans induced by insulin and fatty acids in hepatic cells may contribute to dyslipidemia of insulin resistance.
    Olsson U; Egnell AC; Lee MR; Lundén GO; Lorentzon M; Salmivirta M; Bondjers G; Camejo G
    Diabetes; 2001 Sep; 50(9):2126-32. PubMed ID: 11522680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular consequences of the association of apoB lipoproteins with proteoglycans. Potential contribution to atherogenesis.
    Hurt-Camejo E; Olsson U; Wiklund O; Bondjers G; Camejo G
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1011-7. PubMed ID: 9194748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative modifications of LDL increase its binding to extracellular matrix from human aortic intima: influence of lesion development, lipoprotein lipase and calcium.
    Wang X; Greilberger J; Ratschek M; Jürgens G
    J Pathol; 2001 Sep; 195(2):244-50. PubMed ID: 11592105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The functional role of arterial intima. Endogenous and exogenous pathogens and specificity of atheromatosis as an inflammation].
    Titov VN
    Klin Lab Diagn; 2003 Feb; (2):23-4, 33-7. PubMed ID: 12688211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteoglycans contribution to association of Lp(a) and LDL with smooth muscle cell extracellular matrix.
    Lundstam U; Hurt-Camejo E; Olsson G; Sartipy P; Camejo G; Wiklund O
    Arterioscler Thromb Vasc Biol; 1999 May; 19(5):1162-7. PubMed ID: 10323765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein-matrix interactions in macrovascular disease in diabetes.
    Tannock LR; Chait A
    Front Biosci; 2004 May; 9():1728-42. PubMed ID: 14977582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid mediators that modulate the extracellular matrix structure and function in vascular cells.
    Camejo G; Hurt-Camejo E; Olsson U; Bondjers G
    Curr Atheroscler Rep; 1999 Sep; 1(2):142-9. PubMed ID: 11122703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acids modulate the composition of extracellular matrix in cultured human arterial smooth muscle cells by altering the expression of genes for proteoglycan core proteins.
    Olsson U; Bondjers G; Camejo G
    Diabetes; 1999 Mar; 48(3):616-22. PubMed ID: 10078565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cysteine protease cathepsin F is expressed in human atherosclerotic lesions, is secreted by cultured macrophages, and modifies low density lipoprotein particles in vitro.
    Oörni K; Sneck M; Brömme D; Pentikäinen MO; Lindstedt KA; Mäyränpää M; Aitio H; Kovanen PT
    J Biol Chem; 2004 Aug; 279(33):34776-84. PubMed ID: 15184381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ApoB-100 Lipoprotein Complex Formation with Intima Proteoglycans as a Cause of Atherosclerosis and Its Possible Ex Vivo Evaluation as a Disease Biomarker.
    Hurt-Camejo E; Camejo G
    J Cardiovasc Dev Dis; 2018 Jul; 5(3):. PubMed ID: 29966388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention of oxidized LDL by extracellular matrix proteoglycans leads to its uptake by macrophages: an alternative approach to study lipoproteins cellular uptake.
    Kaplan M; Aviram M
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):386-93. PubMed ID: 11231918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages.
    Milosavljevic D; Griglio S; Le Naour G; Chapman MJ
    Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteoglycans, lipoproteins, and atherosclerosis.
    Srinivasan SR; Radhakrishnamurthy B; Vijayagopal P; Berenson GS
    Adv Exp Med Biol; 1991; 285():373-81. PubMed ID: 1858569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.